(Q30409092)

English

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

Gaston De Serres

2

object named as

Gaston De Serres

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

4

object named as

Guy Boivin

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

9

object named as

Rodica Gilca

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Marie-Ève Hamelin

3

object named as

Marie-Eve Hamelin

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Vladimir Gilca

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Manale Ouakki

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Nicole Boulianne

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Chantal Sauvageau

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Marc Dionne

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Danuta Skowronski

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

7 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

35-41

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Vaccines for seasonal and pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Effect of an immunization program on seasonal influenza hospitalizations in Mexican children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Influenza vaccines for the future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Protective effect of single-dose adjuvanted pandemic influenza vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.10.062

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.10.062

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30409092&oldid=1784934832"